TY - JOUR AU - Ruebner, R. L. AU - Copelovitch, L. AU - Evageliou, N. F. AU - Denburg, M. R. AU - Belasco, J. B. AU - Kaplan, B. S. PY - 2014 DA - 2014// TI - Nephrotic syndrome associated with tyrosine kinase inhibitors for pediatric malignancy: case series and review of the literature JO - Pediatr Nephrol VL - 29 UR - https://doi.org/10.1007/s00467-013-2696-0 DO - 10.1007/s00467-013-2696-0 ID - Ruebner2014 ER - TY - JOUR AU - Ochiai, S. AU - Sato, Y. AU - Minakawa, A. AU - Fukuda, A. AU - Fujimoto, S. PY - 2019 DA - 2019// TI - Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report JO - BMC Nephrol VL - 20 UR - https://doi.org/10.1186/s12882-019-1273-6 DO - 10.1186/s12882-019-1273-6 ID - Ochiai2019 ER - TY - JOUR AU - Mandac Rogulj, I. AU - Matišić, V. AU - Arsov, B. AU - Boban, L. AU - Juginović, A. AU - Molnar, V. AU - Primorac, D. PY - 2019 DA - 2019// TI - Dasatinib-induced nephrotic syndrome: a case of phenoconversion JO - Croat Med J VL - 60 UR - https://doi.org/10.3325/cmj.2019.60.250 DO - 10.3325/cmj.2019.60.250 ID - Mandac Rogulj2019 ER - TY - JOUR AU - Furuto, Y. AU - Hashimoto, H. AU - Namikawa, A. AU - Outi, H. AU - Takahashi, H. AU - Horiuti, H. AU - Honda, K. AU - Shibuya, Y. PY - 2018 DA - 2018// TI - Focal segmental glomerulosclerosis lesion associated with inhibition of tyrosine kinases by lenvatinib: a case report JO - BMC Nephrol VL - 19 UR - https://doi.org/10.1186/s12882-018-1074-3 DO - 10.1186/s12882-018-1074-3 ID - Furuto2018 ER - TY - JOUR AU - Maruyama, K. AU - Chinda, J. AU - Kuroshima, T. AU - Kabara, M. AU - Nakagawa, N. AU - Fujino, T. AU - Yamamoto, Y. AU - Ohsaki, Y. AU - Ogawa, Y. AU - Hasebe, N. PY - 2015 DA - 2015// TI - Minimal change nephrotic syndrome associated with gefitinib and a successful switch to erlotinib JO - Intern Med VL - 54 UR - https://doi.org/10.2169/internalmedicine.54.3661 DO - 10.2169/internalmedicine.54.3661 ID - Maruyama2015 ER - TY - JOUR AU - Estrada, C. C. AU - Maldonado, A. AU - Mallipattu, S. K. PY - 2019 DA - 2019// TI - Therapeutic inhibition of VEGF signaling and associated Nephrotoxicities JO - J Am Soc Nephrol VL - 30 UR - https://doi.org/10.1681/ASN.2018080853 DO - 10.1681/ASN.2018080853 ID - Estrada2019 ER - TY - JOUR AU - Takahashi, D. AU - Nagahama, K. AU - Tsuura, Y. AU - Tanaka, H. AU - Tamura, T. PY - 2012 DA - 2012// TI - Sunitinib-induced nephrotic syndrome and irreversible renal dysfunction JO - Clin Exp Nephrol VL - 16 UR - https://doi.org/10.1007/s10157-011-0543-9 DO - 10.1007/s10157-011-0543-9 ID - Takahashi2012 ER - TY - JOUR AU - Jha, P. K. AU - Vankalakunti, M. AU - Siddini, V. AU - Bonu, R. AU - Prakash, G. K. AU - Babu, K. PY - 2013 DA - 2013// TI - Sunitinib induced nephrotic syndrome and thrombotic microangiopathy JO - Indian J Nephrol VL - 23 UR - https://doi.org/10.4103/0971-4065.107215 DO - 10.4103/0971-4065.107215 ID - Jha2013 ER - TY - JOUR AU - Quintyne, K. I. AU - Neenan, T. AU - Casserly, L. AU - Gupta, R. PY - 2014 DA - 2014// TI - Uncommon side effect with a commonly used targeted agent: sunitinib-induced nephrotic syndrome in a patient with metastatic renal cell carcinoma JO - BMJ Case Rep VL - 2014 UR - https://doi.org/10.1136/bcr-2013-201183 DO - 10.1136/bcr-2013-201183 ID - Quintyne2014 ER - TY - JOUR AU - London, C. A. AU - Malpas, P. B. AU - Wood-Follis, S. L. AU - Boucher, J. F. AU - Rusk, A. W. AU - Rosenberg, M. P. AU - Henry, C. J. AU - Mitchener, K. L. AU - Klein, M. K. AU - Hintermeister, J. G. AU - Bergman, P. J. AU - Couto, G. C. AU - Mauldin, G. N. AU - Michels, G. M. PY - 2009 DA - 2009// TI - Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-1860 DO - 10.1158/1078-0432.CCR-08-1860 ID - London2009 ER - TY - JOUR AU - Piscoya, S. L. AU - Hume, K. R. AU - Balkman, C. E. PY - 2018 DA - 2018// TI - A retrospective study of proteinuria in dogs receiving toceranib phosphate JO - Can Vet J VL - 59 ID - Piscoya2018 ER - TY - JOUR AU - Tjostheim, S. S. AU - Stepien, R. L. AU - Markovic, L. E. AU - Stein, T. J. PY - 2016 DA - 2016// TI - Effects of toceranib phosphate on systolic blood pressure and proteinuria in dogs JO - J Vet Intern Med VL - 30 UR - https://doi.org/10.1111/jvim.13951 DO - 10.1111/jvim.13951 ID - Tjostheim2016 ER - TY - JOUR AU - Hahn, K. A. AU - Ogilvie, G. AU - Rusk, T. AU - Devauchelle, P. AU - Leblanc, A. AU - Legendre, A. PY - 2008 DA - 2008// TI - Masitinib is safe and effective for the treatment of canine mast cell tumors JO - J Vet Intern Med VL - 22 UR - https://doi.org/10.1111/j.1939-1676.2008.0190.x DO - 10.1111/j.1939-1676.2008.0190.x ID - Hahn2008 ER - TY - JOUR AU - Devine, L. AU - Polzin, D. J. PY - 2016 DA - 2016// TI - Presumed masitinib-induced nephrotic syndrome and azotemia in a dog JO - Can Vet J VL - 57 ID - Devine2016 ER - TY - JOUR AU - Crivellenti, L. Z. AU - Silva, G. E. AU - Borin-Crivellenti, S. AU - Cianciolo, R. AU - Adin, C. A. AU - Dantas, M. PY - 2016 DA - 2016// TI - Prevalence of glomerulopathies in canine mammary carcinoma JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0164479 DO - 10.1371/journal.pone.0164479 ID - Crivellenti2016 ER - TY - JOUR AU - Bella, A. AU - Maurella, C. AU - Cauvin, A. AU - Schmidt, J. M. AU - Tapia, B. B. AU - North, S. M. PY - 2013 DA - 2013// TI - Proteinuria in canine patients with lymphoma JO - J Small Anim Pract VL - 54 UR - https://doi.org/10.1111/jsap.12004.x DO - 10.1111/jsap.12004.x ID - Bella2013 ER - TY - JOUR AU - Izzedine, H. AU - Escudier, B. AU - Lhomme, C. AU - Pautier, P. AU - Rouvier, P. AU - Gueutin, V. AU - Baumelou, A. AU - Derosa, L. AU - Bahleda, R. AU - Hollebecque, A. AU - Sahali, D. AU - Soria, J. C. PY - 2014 DA - 2014// TI - Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center JO - Medicine (Baltimore) VL - 93 UR - https://doi.org/10.1097/MD.0000000000000207 DO - 10.1097/MD.0000000000000207 ID - Izzedine2014 ER - TY - JOUR AU - Bernabe, L. F. AU - Portela, R. AU - Nguyen, S. AU - Kisseberth, W. C. AU - Pennell, M. AU - Yancey, M. F. AU - London, C. A. PY - 2013 DA - 2013// TI - Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose JO - BMC Vet Res VL - 9 UR - https://doi.org/10.1186/1746-6148-9-190 DO - 10.1186/1746-6148-9-190 ID - Bernabe2013 ER - TY - JOUR AU - Wu, H. M. AU - Tang, J. L. AU - Cao, L. AU - Sha, Z. H. AU - Li, Y. PY - 2012 DA - 2012// TI - Interventions for preventing infection in nephrotic syndrome JO - Cochrane Database Syst Rev VL - 2012 ID - Wu2012 ER - TY - JOUR AU - Wei, C. C. AU - Yu, I. W. AU - Lin, H. W. AU - Tsai, A. C. PY - 2012 DA - 2012// TI - Occurrence of infection among children with nephrotic syndrome during hospitalizations JO - Nephrology (Carlton) VL - 17 UR - https://doi.org/10.1111/j.1440-1797.2012.01650.x DO - 10.1111/j.1440-1797.2012.01650.x ID - Wei2012 ER - TY - JOUR AU - Carpenter, S. L. AU - Goldman, J. AU - Sherman, A. K. AU - Selewski, D. T. AU - Kallash, M. AU - Tran, C. L. PY - 2019 DA - 2019// TI - Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome JO - Pediatr Nephrol VL - 34 UR - https://doi.org/10.1007/s00467-018-4072-6 DO - 10.1007/s00467-018-4072-6 ID - Carpenter2019 ER - TY - JOUR AU - Kodner, C. PY - 2016 DA - 2016// TI - Diagnosis and management of nephrotic syndrome in adults JO - Am Fam Physician VL - 93 ID - Kodner2016 ER - TY - JOUR AU - Klosterman, E. S. AU - Moore, G. E. AU - Brito Galvao, J. F. AU - DiBartola, S. P. AU - Groman, R. P. AU - Whittemore, J. C. PY - 2011 DA - 2011// TI - Comparison of Signalment, Clinicopathologic findings, histologic diagnosis, and prognosis in dogs with glomerular disease with or without Nephrotic syndrome JO - J Vet Intern Med VL - 25 UR - https://doi.org/10.1111/j.1939-1676.2010.0669.x DO - 10.1111/j.1939-1676.2010.0669.x ID - Klosterman2011 ER - TY - JOUR AU - Klosterman, E. S. AU - Pressler, B. M. PY - 2011 DA - 2011// TI - Nephrotic syndrome in dogs: clinical features and evidence-based treatment considerations JO - Top Companion Anim Med VL - 26 UR - https://doi.org/10.1053/j.tcam.2011.04.004 DO - 10.1053/j.tcam.2011.04.004 ID - Klosterman2011 ER - TY - JOUR AU - Vivarelli, M. AU - Massella, L. AU - Ruggiero, B. AU - Emma, F. PY - 2017 DA - 2017// TI - Minimal change disease JO - Clin J Am Soc Nephrol VL - 12 UR - https://doi.org/10.2215/CJN.05000516 DO - 10.2215/CJN.05000516 ID - Vivarelli2017 ER -